Table 4 |
|||
|
Comparison of outpatients and hospitalized patients with Mycoplasma pneumoniae pneumonia |
|||
|
Variable |
Outpatients N = 171 |
p value |
Hospitalized patients N = 136 |
|
|
|||
|
Age [∅ ± SD] |
38 ± 13.1 |
.000 |
45 ± 18.4 |
|
|
|||
|
Male gender |
44% |
.320 |
38% |
|
|
|||
|
CRB – 65 score |
|||
|
|
|||
|
0 |
79% |
.002 |
64% |
|
|
|||
|
1 – 2 |
20%/1% |
30%/5% |
|
|
|
|||
|
3 – 4 |
0 |
1% - 0 |
|
|
|
|||
|
Smoker |
39% |
.185 |
32% |
|
|
|||
|
COPD |
18% |
.239 |
23% |
|
|
|||
|
Diabetes |
0.6% |
.013 |
5.1% |
|
|
|||
|
Malignancy |
2% |
.946 |
2% |
|
|
|||
|
|
|||
|
CRP median (mg/l) |
33 |
.000 |
90 |
|
|
|||
|
Leucocytes median (103/μl) |
7900 |
.000 |
10300 |
|
|
|||
|
|
|||
|
Respiratory sample available |
68% |
.000 |
46% |
|
|
|||
|
Serum available |
98% |
.112 |
94% |
|
|
|||
|
|
|||
|
Received antibiotic therapy active against atypical bacteria |
64% |
.306 |
70% |
|
|
|||
|
Length of antimicrobial therapy (days) |
10.6 ± 4.1 |
.026 |
11.6 ± 3.6 |
|
|
|||
|
Dyspnoea |
60% |
.000 |
80% |
|
|
|||
|
O 2 application |
2% |
.000 |
55% |
|
|
|||
|
Died (30 day mortality) |
0 |
.112 |
2 patients |
|
|
|||
|
von Baum et al. BMC Infectious Diseases 2009 9:62 doi:10.1186/1471-2334-9-62 |
|||
